We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$168M
AUM Growth
-$47.9M
Cap. Flow
-$34.3M
Cap. Flow %
-20.4%
Top 10 Hldgs %
60.49%
Holding
95
New
8
Increased
17
Reduced
13
Closed
10

Top Buys

1
IOVA icon
Iovance Biotherapeutics
IOVA
+$5.12M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$2.13M
3
RLMD icon
Relmada Therapeutics
RLMD
+$2.08M
4
ARDX icon
Ardelyx
ARDX
+$1.37M
5
TGTX icon
TG Therapeutics
TGTX
+$1.34M

Top Sells

1
CLMT icon
Calumet Specialty Products
CLMT
+$44M
2
CPRX icon
Catalyst Pharmaceutical
CPRX
+$1.64M
3
TECX
Tectonic Therapeutic
TECX
+$1.54M
4
TVTX icon
Travere Therapeutics
TVTX
+$1.36M
5
BHVN icon
Biohaven
BHVN
+$1.25M

Sector Composition

1 Healthcare 53.57%
2 Financials 19.49%
3 Communication Services 15.66%
4 Technology 1.31%
5 Energy 0.51%

No holdings matched the selected filter criteria.

1 2 3 4

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
TT
TI-Trust Quincy, Illinois $168M AUM 24.32% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return

David M. Knott Jr's Q1 2026 Portfolio in Review

As of Q1 2026, David M. Knott Jr held 95 positions worth $168M, down 22% from $216M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

David M. Knott Jr withdrew a net $34.3M in Q1 2026, closing 10 positions and reducing 13 holdings. Its most notable exit was Calumet Specialty Products, an estimated $44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 41% a quarter earlier, followed by Financials and Communication Services.

Against the trend, David M. Knott Jr opened a new position in Iovance Biotherapeutics worth $5.62M.

  • David M. Knott Jr's largest Q1 2026 buy was Iovance Biotherapeutics: 1,600,000 shares worth $5.62M.
  • David M. Knott Jr added most to Agios Pharmaceuticals in Q1 2026, an estimated $2.13M increase.
  • David M. Knott Jr's biggest Q1 2026 reduction was Catalyst Pharmaceutical, cutting an estimated $1.64M.
  • David M. Knott Jr fully exited Calumet Specialty Products in Q1 2026, selling an estimated $44M.
  • David M. Knott Jr's ten largest holdings make up 60% of its $168M portfolio in Q1 2026.
  • David M. Knott Jr opened 8 new positions and closed 10 in Q1 2026.
  • David M. Knott Jr's portfolio value fell 22% quarter-over-quarter to $168M.

Based on David M. Knott Jr's 13F filing for Q1 2026, filed 14 May 2026.